Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. The large number of journeys and participation in events have enabled him to build up a personal network.
As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders. Besides precious metals and energy sources, innovations from various industries are of particular interest.
Since the 1990s, extensive experience in the capital market from various perspectives has been gained. The anecdotes from this time are now paired with the expert knowledge from his business studies in the current commentaries in an entertaining way.
Commented by Mario Hose
Commented by Mario Hose on January 17th, 2022 | 15:57 CET
Which stocks should investors buy? BioNTech, Desert Gold, Unilever in focus
The start of the week in Germany has been mixed. At 15,937 points, the German benchmark index DAX is almost unchanged from the close of trading last Friday. No impulses are expected from the U.S. today, as the stock market there remains closed for the holiday. The MDAX last traded at 34,667 points (+0.24%), TecDAX at 3,563 points (+0.53%) and SDAX at 15,872 points with 0.07% in the red. Detached from the indices, investors have special opportunities today in individual stocks.
Read
Commented by Mario Hose on January 14th, 2022 | 12:17 CET
Natural active ingredient against Covid-19: BioNTech, Cardiol, Novavax, Valneva in focus
At the end of the week, trading on the German stock exchanges has been rather slow so far. The German leading index DAX is quoted at a level of 15,922 points and thus around 0.01% up. The index of the second tier, MDAX, traded last at 34,626 points (-0.11%), TecDAX at 3,537 points (-0.67%) and SDAX at 15,904 points with 0.43% in the red. A study from the U.S. will influence the future development of vaccine manufacturers in connection with Covid-19, according to initial research.
Read
Commented by Mario Hose on January 13th, 2022 | 18:11 CET
New research results for Covid-19: BioNTech, Cardiol, Valneva
In the afternoon of today's trading day, the German indices extended the price losses in part after a brief recovery phase. The DAX is currently trading at 15,963 points, down around 0.41%. The psychological mark of 16,000 points was exceeded at midday in phases by more than 75 points. The MDAX last traded at 34,708 points (-0.62%), TecDAX at 3,577 points (-2.26%) and SDAX at 15,976 points with 0.66% in the red. New research results for the treatment and prevention of Covid-19 provide an exciting perspective for investors.
Read
Commented by Mario Hose on January 13th, 2022 | 12:01 CET
Stocks offer trading opportunities: BrainChip, TeamViewer, XPhyto
On Thursday, most German indices started trading with negative signs. The DAX is currently trading at 15,989 points, down around 0.25%. The psychological mark of 16,000 points has not held compared to the previous day. The MDAX last traded at 34,874 points (-0.14%), TecDAX at 3,637 points (-0.62%) and SDAX at 16,062 points with 0.13% in the red. In the single stocks, on the other hand, there are exciting developments for the stock traders.
Read
Commented by Mario Hose on January 12th, 2022 | 13:17 CET
Energy stocks after oil price rise: BP, Saturn Oil + Gas, Shell
The price of energy continues to be the focus of the public and investors in the new year. The price of WTI crude oil reached a new high for the year on Wednesday at almost USD 82.00 per barrel. Brent crude is currently trading at over USD 84.00 per barrel. Also, the price of Natural Gas of February 2022 contracts has increased today by 4.73% to 4.45 USD. The development in the commodity market also usually reflects in the balance sheets of producers.
Read
Commented by Mario Hose on January 12th, 2022 | 10:53 CET
Trading stocks after EMA warning in focus: BioNTech, Johnson + Johnson, Moderna
On Wednesday, the German indices began with a positive sign. The German benchmark index DAX is currently quoted at a level of 16,004 points and thus around 0.04% slightly up. The companies in the second tier can also hold their ground and the MDAX last traded at 34,864 points (+0.26%), TexDAX at 3,644 points and thus 0.60% lower than the previous day. SDAX also loses and last traded at 15,969 points (-0.23%).
Read
Commented by Mario Hose on January 11th, 2022 | 11:36 CET
Trading stocks in focus: BioNTech, Darktrace, EXMceuticals
Tuesday is under a good omen on the stock market after a failed start to the week. Germany's leading index, the DAX, is trading at 15,961 points, up around 0.32%, but has not yet made it above the psychological 16,000 mark. The MDAX last traded at 34,713 points (+0.42%), TexDAX at 3,661 points (+1.09%) and SDAX at 15,913 points with 0.66% in the plus.
Read
Commented by Mario Hose on January 10th, 2022 | 12:02 CET
Trading stocks in focus: Aspermont, BASF, BioNTech
At the beginning of the week, the DAX is currently trading around 0.19% down at 15,939 points and thus remains below the psychological mark of 16,000 points. The MDAX recently traded again below the 35,000 mark at 34,804 points (-0.52%), TexDAX at 3,653 points (-1.50%) and SDAX at 15,936 points with 1.06% in the red. Overall, the indices had given back their initial gains from the start of trading and are trading in negative territory in the morning.
Read
Commented by Mario Hose on January 7th, 2022 | 16:04 CET
Trading shares in focus: Allianz, BioNTech, BrainChip
At the end of the week, the DAX was down around 0.37% at 15,968 points and thus below the psychological mark of 16,000 points. The MDAX last traded at 35,002 points (-34%), TexDAX at 3,731 points (-0.36%) and SDAX at 16,125 points with 0.92% in the red.
Read
Commented by Mario Hose on July 27th, 2021 | 05:00 CEST
Saturn Oil + Gas CEO John Jeffrey: "Acquisition has increased production by 2,000%"
At year-end 2020, we featured an interview on this platform with Saturn Oil & Gas CEO John Jeffrey. The Company's leader let us in on his plans, announcing an acquisition and recently successfully executing on it. The acquisition of the Oxbow project in southeastern Saskatchewan will give the Company a daily production rate of about 7,000 barrels per day. Due to hedging transactions in the oil price, the Company can already look forward to profitability in 2022, which is higher than the current stock market value. Saturn Oil & Gas is, without doubt, one of the success stories of recent months and has enormous upside potential. We welcome the latest insights from John Jeffrey.
Read